Perspective Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
CATX on NYSE
Location
2401 Elliott Avenue, Suite 320, Seattle, WA

Insiders trading volume in the past year

Perspective Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lantheus Alpha Therapy, LLC 10%+ Owner $111M +$57.4M +107% Mar 6, 2024
Markus Puhlmann Chief Medical Officer $687K +$329K +91.7% Jun 20, 2024
Robert F. Williamson III Director $590K +$319K +118% Jun 20, 2024
Johan M. Spoor CEO, Director $244K +$117K +93% Jun 20, 2024
Lori A. Woods Director $194K +$100K +107% Jun 20, 2024
Jonathan Hunt Chief Financial Officer $42.2K +$67.3K Jun 20, 2024
Mark Austin VP Finance/Prin Fin&Acct Offic $30.3K Jul 17, 2024
Alan Hoffmann Director Jul 21, 2022
William Cavanagh Chief R&D Officer Jul 21, 2022
Philip J. Vitale Director Jul 21, 2022
Frank Morich Director Jun 20, 2024
Michael McCormick Director Feb 21, 2023
Heidi Henson Director Jun 20, 2024
Jennifer Streeter COO & VP of HR Jun 12, 2023

Recent Insider Transactions by Companies or Individuals for Perspective Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.